Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,086,093
+$1,057,545 QoQ
Shares Held
7,685
+49.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#360
of 844 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $798,294,688 across 13 Diagnostics & Research names. NTRA ranks #12 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
316,281 | $158,570,642 | |
| 2 | LH |
Labcorp Holdings Inc.
|
557,016 | $155,964,480 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
101,829 | $130,087,565 | |
| 4 | DHR |
Danaher Corp /De/
|
564,247 | $107,477,768 | |
| 5 | DGX |
Quest Diagnostics Inc
|
485,841 | $102,973,999 | |
| 6 | ICLR |
Icon PLC
|
327,184 | $56,835,132 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
165,515 | $31,980,808 | |
| 8 | SHC |
Sotera Health Co
|
1,730,807 | $30,721,824 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,086,093 | 7,685 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,028,548 | 5,143 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $550,503 | 2,403 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||